50.99 (-%)
As of Nov 01, 2024
Source:
Ultragenyx Pharmaceutical Inc., we or the Company, is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. We target diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are typically no approved therapies treating the underlying disease.
Country | United States |
Headquarters | novato, california |
Phone Number | 415-483-8800 |
Industry | manufacturing |
CEO | Emil D. Kakkis |
Website | www.ultragenyx.com |